A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer

A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers

(2008) Shanbeh Zienolddiny et al.   CARCINOGENESIS

Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer

(2008) Monica Ter-Minassian et al.   CARCINOGENESIS

The Pattern ofp53Mutations Caused by PAHo-Quinones is Driven by 8-oxo-dGuo Formation while the Spectrum of Mutations is Determined by Biological Selection for Dominance

(2008) Jong-Heum Park et al.   CHEMICAL RESEARCH IN TOXICOLOGY

IL1B gene promoter haplotype pairs predict clinical levels of interleukin-1β and C-reactive protein

(2008) John Rogus et al.   HUMAN GENETICS

Is interleukin-1 a good or bad ‘guy’ in tumor immunobiology and immunotherapy?

(2008) Ron N. Apte et al.   IMMUNOLOGICAL REVIEWS

Polymorphisms in interleukin-1B and its receptor antagonist genes and the risk of chronic obstructive pulmonary disease in a Korean population: a case–control study

(2008) Jong Myung Lee et al.   RESPIRATORY MEDICINE

Accounting for haplotype phase uncertainty in linkage disequilibrium estimation

(2007) B. Kulle et al.   GENETIC EPIDEMIOLOGY

Impact of respiratory symptoms on lung cancer: 30-year follow-up of an urban population

(2007) Anne Frostad et al.   LUNG CANCER